Erratum to "Peripheral and central neurologic complications in type 2 diabetes mellitus: No association in individual patients" [J Neurol Sci 264 (2008) 157-162] (DOI:10.1016/j.jns.2007.08.011);Peripheral and central neurologic complications in type 2 diabetes mellitus: No association in individual patients

Journal of the Neurological Sciences

Volumn 264, Issue 1-2, 2008, Pages 157-162

  Manschot, S M ^a   Biessels, G J ^a   Rutten, G E H M ^b   Kessels, R C P ^c   Gispen, W H ^a   Kappelle, L J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Encephalopathy; MRI brain; Neuropsychological investigation; Peripheral neuropathy; Type 2 diabetes mellitus

Indexed keywords

AGED; ARTICLE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PATIENT; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUESTIONNAIRE; VIBRATION SENSE; WHITE MATTER;

EID: 36549032093     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.08.046     Document Type: Erratum

References (21)

1. Gispen W.H., and Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 23 11 (2000) 542-549
2. Manschot S.M., Brands A.M., van der Grond J., Kessels R.P., Algra A., Kappelle L.J., et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55 4 (2006) 1106-1113
3. Ryan C.M., Williams T.M., Orchard T.J., and Finegold D.N. Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes 41 1 (1992) 107-113
4. Ryan C.M., Williams T.M., Finegold D.N., and Orchard T.J. Cognitive dysfunction in adults with type 1 (insuline-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 36 4 (1993) 329-334
5. Perlmuter L.C., Hakami M.K., Hodgson-Harrington C., Ginsberg Y., Katz J., Singer D.E., et al. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med 77 (1984) 1043-1048
6. Zaslavsky L.M., Gross J.L., Chaves M.L., and Machado R. Memory dysfunction and autonomic neuropathy in non-insulin-dependent (type 2) diabetic patients. Diabetes Res Clin Pract 30 2 (1995) 101-110
7. American Diabetes Association. Report of the Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 21 suppl 1 (1998) S5-S19
8. Notermans N.C., Wokke J.H., Franssen H., van der Graaf Y., Vermeulen M., van den Berg L.H., et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 56 10 (1993) 1066-1071
9. Goldberg J.M., and Lindblom U. Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neurol Neurosurg Psychiatry 42 9 (1979) 793-803
10. Bril V., and Perkins B.A. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 25 11 (2002) 2048-2052
11. Scheltens P., Barkhof F., Leys D., Pruvo J.P., Nauta J.J., Vermersch P., et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114 1 (1993) 7-12
12. Gomori J.M., Steiner I., Melamed E., and Cooper G. The assessment of changes in brain volume using combined linear measurements. A CT-scan study. Neuroradiology 26 1 (1984) 21-24
13. Beck A., Ward C., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
14. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 19 (2001) 2486-2497
15. Ewing D.J., Martyn C.N., Young R.J., and Clarke B.F. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8 5 (1985) 491-498
16. Brands A.M., Biessels G.J., De Haan E.H., Kappelle L.J., and Kessels R.P. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28 3 (2005) 726-735
17. Ryan C.M., Geckle M.O., and Orchard T.J. Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 46 7 (2003) 940-948
18. Bloom S., Till S., Sonksen P., and Smith S. Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects. Br Med J (Clin Res Ed) 288 6433 (1984) 1793-1795
19. Dyck P.J., Davies J.L., Wilson D.M., Service F.J., Melton III L.J., and O'Brien P.C. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 22 9 (1999) 1479-1486
20. Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., Pach J.M., et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43 (1993) 817-824
21. Hoogeveen E.K., Kostense P.J., Valk G.D., Bertelsmann F.W., Jakobs C., Dekker J.M., et al. Hyperhomocysteinaemia is not related to risk of distal somatic polyneuropathy: the Hoorn Study. J Intern Med 246 6 (1999) 561-566